Gilead Sciences (GILD) closed the most recent trading day at $69.61, moving -1.58% from the previous trading session.
Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and Crimson Wine are included in this Analyst Blog.
While Gilead Sciences has not been a leader this year, it has led bull runs in the past. In a Thursday story published on Investors.com, Gilead got highlighted for extraordinary results with one of its newest preventive drugs managing HIV infections. This led to a surge in the price of GILD stock and a recapture of the 50-day moving average.